docusate calcium

(redirected from Correctol)
Also found in: Dictionary.

docusate

 [dok´u-sāt]
any of a group of anionic surfactants widely used as emulsifying, wetting, and dispersing agents.
docusate calcium an ionic surfactant used as a stool softener.
docusate potassium an anionic surfactant used as a stool softener; administered orally.
docusate sodium an ionic surfactant used as a stool softener.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

docusate calcium

Apo-Docusate Calcium (CA), Calax (CA), DC Softgels, Novo-Docusate Calcium (CA), PMS-Docusate Calcium (CA), Ratio-Docusate Calcium (CA), Soflax C (CA), Stool Softener DC, Surfak Liquigels

docusate sodium

Apo-Docusate Sodium (CA), Colace, Correctol, Correctol Stool Softener (CA), Diocto, Dioctyl (UK), Docusol (UK), Dom-Docusate Sodium (CA), D.O.S. Softgels, Docu-Soft, DOK, D-S-S, DulcoEase (UK), Dulcolax Stool Softener, Enemeez, Genasoft Softgels, Norgalax (UK), Novo Docusate (CA), PHL-Docusate Sodium (CA), PMS-Docusate Sodium, Ratio-Docusate Sodium (CA), Selax (CA), Silace

Pharmacologic class: Emollient

Therapeutic class: Stool softener, surfactant

Pregnancy risk category C

Action

Increases absorption of liquid into stool, resulting in softening of fecal mass. Also promotes electrolyte and water secretion into colon.

Availability

docusate calcium

Capsules: 240 mg

Capsules (soft gels): 240 mg

Rectal solution: 283 mg/5 ml

docusate sodium

Capsules: 50 mg, 100 mg, 250 mg

Capsules (soft gels): 100 mg, 250 mg

Liquid: 150 mg/15 ml

Syrup: 50 mg/15 ml, 60 mg/15 ml, 20 mg/5 ml, 100 mg/30 ml, 150 mg/15 ml

Tablets: 100 mg

Indications and dosages

Stool softener

Adults and children older than age 12: 240 mg (docusate calcium) or 50 to 200 mg (docusate sodium) P.O. daily until bowel movements are normal

Children ages 6 to 12: 40 to 120 mg (docusate sodium) P.O. daily

Children ages 3 to 6: 20 to 60 mg (docusate sodium) P.O. daily

Contraindications

• Hypersensitivity to drug

• Abdominal pain, nausea, or vomiting

• Intestinal obstruction

Precautions

Use cautiously in:

• pregnant or breastfeeding patients.

Administration

• Give tablets and capsules with full glass of water.

• Give liquid solution with milk or fruit juice.

• Be aware that excessive or long-term use may lead to laxative dependence.

Adverse reactions

EENT: throat irritation

GI: nausea, diarrhea, mild cramps

Skin: rash

Other: bitter taste, decreased appetite, laxative dependence

Interactions

Drug-drug. Mineral oil: increased mineral oil absorption, causing toxicity

Warfarin: decreased warfarin effects (with high doses)

Patient monitoring

• If diarrhea occurs, withhold drug and notify prescriber.

• Know that therapeutic efficacy usually becomes apparent 1 to 3 days after first dose.

Patient teaching

• Instruct patient to drink sufficient fluids with each dose and to increase fluid intake during the day.

• Advise patient to prevent constipation by increasing fluids and consuming more dietary fiber (as in fruits and bran).

• Inform patient that excessive or prolonged use may lead to laxative dependence.

• As appropriate, review all other significant adverse reactions and interactions, especially those related to the drugs mentioned above.

McGraw-Hill Nurse's Drug Handbook, 7th Ed. Copyright © 2013 by The McGraw-Hill Companies, Inc. All rights reserved
References in periodicals archive ?
MEDICATIONS THAT MAY AFFECT CALCIUM ABSORPTION Loop diuretics Furosemide (Lasix), bumetanide (Bumex), torsemide (Demadex) Cortico steroids Cortisone, prednisone, prednisolone (Prelone), methylprednisolone (Medrol) Heartburn medications Esomeprazole magnesium (Nexium), omeprazole (Prilosec), lansoprazole (Prevacid), cimetidine (Tagamet), ranitidine hydrochloride (Zantac) Laxatives Ex-Lax, Correctol If you are taking a medication that affects calcium absorption, Dr.
price Unit sales Unit sales per unit (000) % change Dulcolax $0.17 4,616 + 8.7% Ex-Lax 0.42 1,782 - 11.6% Fleet 0.10 1,467 - 17.2% Metamucil 0.21 1,446 - 17.3% Colace 0.16 1,405 + 0.8% Phillips 0.37 1,145 - 6.9% Correctol 0.75 862 - 20.8% Fiber Choice 0.19 761 - 12.0% Benefiber 0.04 688 + 18.9% Senokot 0.21 504 - 2.1% * Total of drug stores, supermarkets and discount stores excluding Wal-Mart Stores Inc.
(+2%) Market Unit sales Unit sales LEADING BRANDS ** share (000) % change Dulcolax 12.4% 3,981 +3.8% Ex-Lax 6.5% 2,092 -3.8% Fleet 5.9% 1,893 -4.7% Metamucil 5.8% 1,844 -0.8% Colace 3.8% 1,209 +17.3% Correctol 3.7% 1,178 -7.4% Citrucel 2.1% 660 +72.6% Benefiber 1.9% 605 +44.6% Fibercon 1.8% 563 -18.0% Senokot 1.6% 527 +23.6% * Total of drug stores, supermarkets and discount stores excluding Wal-Mart Stores Inc.
Fleet 3.2% 7,802 Senokot Purdue Products 3.0% 7,306 Correctol Schering-Plough 2.8% 6,779 Citrucel GlaxoSmithKline 2.7% 6,653 Market Unit sales Leading brands ** Manufacturer share (000) Dulcolax Boehringer Ingelheim 12.3% 3,777 Ex-Lax Novartis 6.9% 2,110 Fleet C.B.
Fleet 3.5% Correctol Schering-Plough 3.0% Citrucel GlaxoSmithKline 3.0% Surfak Pharmacia 2.0% Fiber Choice CNS 1.5% Dollar sales Unit sales Brand (add 000) (add 000) Dulcolax $28,838 3,782 Metamucil 15,783 1,863 Ex-Lax 15,199 2,216 COlace 12,896 866 Fibercon 9,681 790 Fleet 8,364 2,120 Correctol 7,252 1,322 Citrucel 7,152 466 Surfak 4,799 454 Fiber Choice 3,587 367 * Private label brands account for 42.1% of dollar sales and 45% of unit sales.
Fleet 3.2% 8,244 Correctol Schering-Plough 3.1% 7,956 Senokot Purdue Frederick 3.1% 7,955 Citrucel GlaxoSmithKline 3.0% 7,759 Unit sales: Total * 58.9 mil.
Fleet 3.2% 8,228 Correctol Schering-Plough 3.1% 8,058 Citrucel GIaxoSmithKline 3.0% 7,906 Unit sales Brand (add 000) Dulcolax 3,234 Ex-Lax 2,399 Metamucil 1,982 Colace 1,225 Fibercon 1,066 Senokot S 630 Senokot 661 Fleet 2,155 Correctol 1,478 Citrucel 514 * Private label brands account for 36.6% of dollar sales and 41.7% of unit sales.
LAXATIVE TABLES Market Dollar sales Leading drug store brands Manufacturer share (000) Dulcolax Novartis 9.5% $23,515 Ex-Lax Novartis 6.5% 16,117 Senokot S Purdue Frederick 6.4% 15,851 Colace Bristol-Myers Squibb 6.4% 15,711 Fibercon Whitehall-Robins 5.7% 14,150 Senokot Purdue Frederick 5.7% 14,063 Correctol Schering-Plough 3.5% 8,706 Fleet C.B.
year ago Total mass market + -0.8% Drug stores +1.0% Supermarkets -3.7% Best-sellers by dollar sales * Market Dollar sales Unit sales Brand Manufacturer share (add 000) (add 000) Dulcolax Novartis 9.4% 35,904 4,939 Ex-Lax Novartis 9.1% 34,506 6,203 Fibercan Whitehall-Robins 7.5% 28,596 2,708 Senokot Purdue Frederick 6.5% 24,599 1,953 Senokat S Purdue Frederick 5.5% 21,069 1,331 Correctol Schering-Plough 5.3% 20,006 3,725 Colace Bristol-Myers Squibb 5.2% 19,963 1,744 Fleet C.B.